Insufficient scRNA-seq data for expression of FBXL21P at single-cell level.
Insufficient scRNA-seq data for expression of FBXL21P at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 177.42 | 89 / 89 | 58% | 3.29 | 523 / 901 |
adrenal gland | 95% | 80.29 | 244 / 258 | 17% | 1.08 | 40 / 230 |
prostate | 93% | 428.94 | 228 / 245 | 6% | 0.11 | 31 / 502 |
ovary | 80% | 55.93 | 144 / 180 | 13% | 0.42 | 55 / 430 |
brain | 75% | 61.43 | 1992 / 2642 | 2% | 0.06 | 17 / 705 |
liver | 61% | 21.38 | 137 / 226 | 16% | 0.43 | 63 / 406 |
bladder | 67% | 438.38 | 14 / 21 | 2% | 0.06 | 10 / 504 |
stomach | 44% | 14.70 | 158 / 359 | 1% | 0.02 | 4 / 286 |
thymus | 19% | 4.88 | 121 / 653 | 6% | 0.16 | 39 / 605 |
spleen | 23% | 22.59 | 55 / 241 | 0% | 0 | 0 / 0 |
esophagus | 14% | 8.83 | 207 / 1445 | 7% | 0.14 | 12 / 183 |
uterus | 5% | 1.55 | 8 / 170 | 10% | 0.56 | 44 / 459 |
skin | 7% | 1.89 | 124 / 1809 | 7% | 0.63 | 32 / 472 |
lung | 0% | 0.07 | 2 / 578 | 11% | 0.35 | 124 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.34 | 3 / 45 |
breast | 5% | 1.84 | 25 / 459 | 1% | 0.02 | 8 / 1118 |
pancreas | 1% | 0.13 | 2 / 328 | 2% | 0.04 | 4 / 178 |
adipose | 2% | 0.51 | 28 / 1204 | 0% | 0 | 0 / 0 |
intestine | 1% | 0.79 | 9 / 966 | 0% | 0 | 0 / 527 |
blood vessel | 0% | 0.03 | 2 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.02 | 1 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.02 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0016567 | Biological process | protein ubiquitination |
GO_0031146 | Biological process | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
GO_0048511 | Biological process | rhythmic process |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
Gene name | FBXL21P |
Protein name | FBXL21 protein Putative F-box/LRR-repeat protein 21 (F-box and leucine-rich repeat protein 21) (F-box and leucine-rich repeat protein 3B) (F-box/LRR-repeat protein 3B) |
Synonyms | FBL3 FBXL3B FBL21 FBXL3P FBXL21 |
Description | FUNCTION: Substrate-recognition component of the SCF(FBXL21) E3 ubiquitin ligase complex involved in circadian rhythm function. Plays a key role in the maintenance of both the speed and the robustness of the circadian clock oscillation. The SCF(FBXL21) complex mainly acts in the cytosol and mediates ubiquitination of CRY proteins (CRY1 and CRY2), leading to CRY proteins stabilization. The SCF(FBXL21) complex counteracts the activity of the SCF(FBXL3) complex and protects CRY proteins from degradation. Involved in the hypothalamic suprachiasmatic nucleus (SCN) clock regulating temporal organization of the daily activities (By similarity). . |
Accessions | Q3KPF8 Q9UKT6 |